Domov › Rakovina prsníka › Kalifornia › Santa Monica
Klinické štúdie Rakovina prsníka v meste Santa Monica, CA
28 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Santa Monica a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Prebieha náborFáza 3
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A Study of PHST001 in Advanced Solid Tumors
Prebieha náborFáza 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 míľ odtiaľ
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Prebieha náborFáza 2
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Prebieha náborFáza 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Prebieha nábor
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
Prebieha náborFáza 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 míľ odtiaľ
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Prebieha náborFáza 3
- Clinical Trial Site, Beverly Hills · 6 míľ odtiaľ
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Prebieha náborFáza 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Prebieha náborFáza 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Prebieha náborFáza 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Prebieha náborFáza 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 míľ odtiaľ
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Prebieha náborFáza 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Prebieha náborFáza 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Prebieha náborFáza 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- a 1 ďalších
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 míľ odtiaľ
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 míľ odtiaľ
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Prebieha náborFáza 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 míľ odtiaľ
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Prebieha náborFáza 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 míľ odtiaľ
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Prebieha náborFáza 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
Prebieha náborFáza 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 míľ odtiaľ
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Prebieha náborFáza 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 míľ odtiaľ
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 míľ odtiaľ
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Prebieha náborFáza 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Prebieha náborFáza 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 míľ odtiaľ
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Prebieha náborObservačná štúdia
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Santa Monica
- Nemalobunkový karcinóm pľúc45 štúdií
- Kolorektálny karcinóm23 štúdií
- Rakovina (všetky typy)22 štúdií
- Metastatická rakovina19 štúdií
- Rakovina pľúc15 štúdií
- Rakovina vaječníkov15 štúdií
- Rakovina prostaty15 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku13 štúdií
- Srdcové zlyhanie11 štúdií
- Rakovina endometria10 štúdií
- Rakovina žalúdka9 štúdií
- Rakovina pankreasu9 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.